Patient-reported outcomes in postmenopausal breast cancer survivors – comparisons with normative data

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Rojas K, Stuckey A. Breast cancer epidemiology and risk factors. Clin Obstet Gynecol. 2016;59(4):651–672.
   PubMed Web of Science ®Google Scholar
• Netuveli G, Wiggins RD, Hildon Z, et al. Quality of life at older ages: evidence from the English longitudinal study of aging (wave 1). J Epidemiol Community Health. 2006;60(4):357–363.
   PubMed Web of Science ®Google Scholar
• Layte R, Sexton E, Savva G. Quality of life in older age: evidence from an Irish cohort study. J Am Geriatr Soc. 2013;61:S299–S305.
   PubMed Web of Science ®Google Scholar
• Ganz PA, Desmond KA, Leedham B, et al. Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. CancerSpectrum Knowl Environ. 2002;94(1):39–49.
   Google Scholar
• DiSipio T, Rye S, Newman B, et al. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013;14(6):500–515.
   PubMed Web of Science ®Google Scholar
• Levangie PK, Drouin J. Magnitude of late effects of breast cancer treatments on shoulder function: a systematic review. Breast Cancer Res Treat. 2009;116(1):1–15.
   PubMed Web of Science ®Google Scholar
• Bartelink H, Maingon P, Poortmans P, et al. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial. Lancet Oncol. 2015;16(1):47–56.
   PubMed Web of Science ®Google Scholar
• Bao T, Basal C, Seluzicki C, et al. Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk. Breast Cancer Res Treat. 2016;159(2):327–333.
   PubMed Web of Science ®Google Scholar
• Hong D, Bi L, Zhou J, et al. Incidence of menopausal symptoms in postmenopausal breast cancer patients treated with aromatase inhibitors. Oncotarget. 2017;8(25):40558–40567.
   PubMedGoogle Scholar
• Bardwell WA, Profant J, Casden DR, for the Women's Healthy Eating & Living (WHEL) Study Group, et al. The relative importance of specific risk factors for insomnia in women treated for early-stage breast cancer. Psychooncology. 2008;17(1):9–18.
   PubMed Web of Science ®Google Scholar
• Johannsen M, Christensen S, Zachariae R, et al. Socio-demographic, treatment-related, and health behavioral predictors of persistent pain 15 months and 7-9 years after surgery: a nationwide prospective study of women treated for primary breast cancer. Breast Cancer Res Treat. 2015;152(3):645–658.
   PubMed Web of Science ®Google Scholar
• Carreira H, Williams R, Müller M, et al. Associations between breast cancer survivorship and adverse mental health outcomes: a systematic review. JNCI J Natl Cancer Inst. 2018;110(12):1311–1327.
   Web of Science ®Google Scholar
• Lyngholm CD, Christiansen PM, Damsgaard TE, et al. Long-term follow-up of late morbidity, cosmetic outcome and body image after breast conserving therapy. A study from the Danish Breast Cancer Cooperative Group (DBCG). Acta Oncol. 2013;52(2):259–269.
   PubMed Web of Science ®Google Scholar
• Lagendijk M, van Egdom LSE, Richel C, et al. Patient reported outcome measures in breast cancer patients. Eur J Surg Oncol. 2018;44(7):963–968.
   PubMed Web of Science ®Google Scholar
• Brouwers PJAM, van Loon J, Houben RMA, et al. Are PROMs sufficient to record late outcome of breast cancer patients treated with radiotherapy? A comparison between patient and clinician reported outcome through an outpatient clinic after 10years of follow up. Radiother Oncol. 2018;126(1):163–169.
   PubMed Web of Science ®Google Scholar
• Hsu T, Ennis M, Hood N, et al. Quality of life in long-term breast cancer survivors. J Clin Oncol. 2013;31(28):3540–3548.
   PubMed Web of Science ®Google Scholar
• de Ligt KM, Heins M, Verloop J, et al. The impact of health symptoms on health-related quality of life in early-stage breast cancer survivors. Breast Cancer Res Treat. 2019;178(3):703–711.
   PubMed Web of Science ®Google Scholar
• Koch L, Jansen L, Herrmann A, et al. Quality of life in long-term breast cancer survivors – a 10-year longitudinal population-based study. Acta Oncol Stockh Swed. 2013;52(6):1119–1128.
   PubMed Web of Science ®Google Scholar
• Götze H, Taubenheim S, Dietz A, et al. Comorbid conditions and health-related quality of life in long-term cancer survivors-associations with demographic and medical characteristics. J Cancer Surviv. 2018;12(5):712–720.
   PubMed Web of Science ®Google Scholar
• Klein D, Mercier M, Abeilard E, et al. Long-term quality of life after breast cancer: a French registry-based controlled study. Breast Cancer Res Treat. 2011;129(1):125–134.
   PubMed Web of Science ®Google Scholar
• Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–483.
   PubMed Web of Science ®Google Scholar
• Kroenke CH, Rosner B, Chen WY, et al. Functional impact of breast cancer by age at diagnosis. J Cin Oncol. 2004;22(10):1849–1856.
   PubMed Web of Science ®Google Scholar
• Karlsen RV, Frederiksen K, Larsen MB, et al. The impact of a breast cancer diagnosis on health-related quality of life. A prospective comparison among middle-aged to elderly women with and without breast cancer. Acta Oncol. 2016;55(6):720–727.
   PubMed Web of Science ®Google Scholar
• Stover AM, Mayer DK, Muss H, et al. Quality of life changes during the pre- to postdiagnosis period and treatment-related recovery time in older women with breast cancer. Cancer. 2014;120(12):1881–1889.
   PubMed Web of Science ®Google Scholar
• Avis NE, Levine B, Goyal N, et al. Health-related quality of life among breast cancer survivors and noncancer controls over 10 years: Pink SWAN . Cancer. 2020;126(10):2296–2304.
   PubMed Web of Science ®Google Scholar
• Browall M, Östlund U, Henoch I, et al. The course of Health Related Quality of Life in postmenopausal women with breast cancer from breast surgery and up to five years post-treatment. The Breast. 2013;22(5):952–957.
   PubMed Web of Science ®Google Scholar
• Ware J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220–233.
   PubMed Web of Science ®Google Scholar
• Neuner JM, Zokoe N, McGinley EL, et al. Quality of life among a population-based cohort of older patients with breast cancer. Breast. 2014;23(5):609–616.
   PubMed Web of Science ®Google Scholar
• Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–376.
   PubMed Web of Science ®Google Scholar
• Sprangers MA, Groenvold M, Arraras JI, et al. The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol off J Am Soc Clin Oncol. 1996;14(10):2756–2768.
   PubMed Web of Science ®Google Scholar
• Basch E, Reeve BB, Mitchell SA, et al. Development of the National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Natl Cancer Inst. 2014;106(9):dju244.
   Google Scholar
• Fayers PM, Aaronson N, Bjordal K, et al. EORTC QLQ-C30 scoring manual. 3rd ed. Brussels: European Organization for Research and Treatment of Cancer; 2001.
   Google Scholar
• Juul T, Petersen MA, Holzner B, et al. Danish population-based reference data for the EORTC QLQ-C30: associations with gender, age and morbidity. Qual Life Res. 2014;23(8):2183–2193.
   PubMed Web of Science ®Google Scholar
• Cohen J. Statistical power analysis for the behavioral sciences. Hillsdale, N.J.: Lawrence Erlbaum Associates; 1988.
   Google Scholar
• Aickin M, Gensler H. Adjusting for multiple testing when reporting research results: the Bonferroni vs Holm methods. AM J Public Health. 1996;86(5):726–728.
   Google Scholar
• Musoro JZ, Coens C, Fiteni F, EORTC Breast and Quality of Life Groups, et al. Minimally important differences for interpreting EORTC QLQ-C30 scores in patients with advanced breast cancer. JNCI Cancer Spectr. 2019;3(3):pkz037.
   PubMed Web of Science ®Google Scholar
• Groenvold M, Fayers PM, Petersen MA, et al. Breast cancer patients on adjuvant chemotherapy report a wide range of problems not identified by health-care staff. Breast Cancer Res Treat. 2007;103(2):185–195.
   PubMed Web of Science ®Google Scholar
• Amidi A, Christensen S, Mehlsen M, et al. Long-term subjective cognitive functioning following adjuvant systemic treatment: 7-9 years follow-up of a nationwide cohort of women treated for primary breast cancer. Br J Cancer. 2015;113(5):794–801.
   PubMed Web of Science ®Google Scholar
• Broadbent DE, Cooper PF, FitzGerald P, et al. The Cognitive Failures Questionnaire (CFQ) and its correlates. Br J Clin Psychol. 1982;21(1):1–16.
   PubMed Web of Science ®Google Scholar
• Bridger RS, Johnsen SÅK, Brasher K. Psychometric properties of the Cognitive Failures Questionnaire. Ergonomics. 2013;56(10):1515–1524.
   PubMed Web of Science ®Google Scholar
• Gerlich C, Schuler M, Jelitte M, et al. Prostate cancer patients' quality of life assessments across the primary treatment trajectory: 'True' change or response shift? Acta Oncol. 2016;55(7):814–820.
   PubMed Web of Science ®Google Scholar
• Bower JE, Ganz PA, Desmond KA, et al. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol off J Am Soc Clin Oncol. 2000;18(4):743–753.
   PubMed Web of Science ®Google Scholar
• Kindts I, Laenen A, van den Akker M, et al. PROMs following breast-conserving therapy for breast cancer: results from a prospective longitudinal monocentric study. Support Care Cancer. 2019;27(11):4123–4132.
   PubMed Web of Science ®Google Scholar
• Lazarewicz MA, Wlodarczyk D, Lundgren S, et al. Diversity in changes of HRQoL over a 1-year period after radiotherapy in Norwegian breast cancer patients: results of cluster analyses. Qual Life Res. 2019;28(6):1521–1530.
   PubMed Web of Science ®Google Scholar
• Simard S, Thewes B, Humphris G, et al. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv. 2013;7(3):300–322.
   PubMed Web of Science ®Google Scholar